Cytek Biosciences (CTKB) Operating Income (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Cytek Biosciences | - | - | 21.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -230.05% |
| Dec 31, 2025 | 39.14% |
| Sep 30, 2025 | 13.48% |
| Jun 30, 2025 | 29.06% |
| Mar 31, 2025 | -601.51% |
| Dec 31, 2024 | 170.29% |
| Sep 30, 2024 | 50.18% |
| Jun 30, 2024 | 20.56% |
| Mar 31, 2024 | -7,735.04% |
| Dec 31, 2023 | 97.87% |
| Sep 30, 2023 | 29.66% |
| Jun 30, 2023 | 24.95% |
| Mar 31, 2023 | -14,578.57% |
| Dec 31, 2022 | -93.82% |
| Sep 30, 2022 | 252.64% |
| Jun 30, 2022 | 62.20% |
| Mar 31, 2022 | -278.97% |
| Dec 31, 2021 | -54.54% |
| Sep 30, 2021 | -23.98% |
| Jun 30, 2021 | 236.66% |
| Mar 31, 2021 | -85.63% |
| Dec 31, 2020 | 17.36% |
| Sep 30, 2020 | 3,178.44% |